SCHEMBL4711255

SCHEMBL4711255

CCOC(=O)c1cnc(SC)cc1N

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.50
MAPT P10636 2/20 0.50
HSP90AA1 P07900 1/20 0.48
RAB9A P51151 5/20 0.47
NPC1 O15118 4/20 0.47
ALDH1A1 P00352 8/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
HSD17B10 Q99714 2/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
TP53 P04637 1/20 0.45
CSNK1D P48730 1/20 0.45
POLB P06746 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
DPP4 P27487 1/20 0.44
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1812364 0.84 ALDH1A1 (0.54) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL31523057 0.83 KDM4E (0.47) KDM4EMAPTALDH1A1HSD17B10POLB
SCHEMBL2445600 0.79 HSP90AA1 (0.50) KDM4EMAPTHSP90AA1RAB9ANPC1
SCHEMBL25534204 0.79 HSP90AA1 (0.50) KDM4EMAPTHSP90AA1RAB9ANPC1
SCHEMBL29374466 0.79 HSP90AA1 (0.50) KDM4EMAPTHSP90AA1RAB9ANPC1
SCHEMBL31523243 0.78 GABRP (0.47) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL2228754 0.78 GABRP (0.47) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL31523679 0.75 KDM4E (0.59) KDM4EMAPTHSP90AA1RAB9ANPC1
SCHEMBL7471868 0.75 ALDH1A1 (0.63) KDM4EMAPTRAB9ANPC1ALDH1A1
SCHEMBL29546526 0.73 ALDH1A1 (0.70) KDM4EMAPTRAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8975250-B2 5 oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseases SANOFI (FR) 2015-03-10 US disclosed
US-20120277220-A1 5 OXO-5,8-DIHYDROPYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AS CAMKII KINASE INHIBITORS FOR TREATING CARDIOVASCULAR DISEASES SANOFI (FR) 2012-11-01 US disclosed
EP-1307450-B1 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7-ones WARNER LAMBERT CO (US) 2008-09-17 EP disclosed
US-7022711-B2 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones WARNER-LAMBERT COMPANY (US) 2006-04-04 US disclosed
US-20030220345-A1 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimdin-7-ones HAMBY JAMES MARINO (US) 2003-11-27 US disclosed
EP-1307450-A2 2-(4-PYRDYL)AMINO-6-DIALKOXYPHENYL-PYRIDO(2.3-D)PYRIMIDIN-7-ONES WARNER-LAMBERT COMPANY (US) 2003-05-07 EP disclosed
WO-2002012238-A2 2-(4-PYRIDYL)AMINO-6-DIALKOXYPHENYL-PYRIDO[2,3-d]PYRIMIDIN-7-ONES WARNER-LAMBERT COMPANY (US) 2002-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220345-A1 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimdin-7-ones FLT1, FLT4, MKI67 KDM4E 1519/4885MAPT 2539/4885HSP90AA1 4164/4885
US-20120277220-A1 5 OXO-5,8-DIHYDROPYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AS CAMKII KINASE INHIBITORS FOR TREATING CARDIOVASCULAR DISEASES CAMKK1, CAMKK2, CAMK1 KDM4E 2091/4885MAPT 3104/4885HSP90AA1 2806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.